Cipla logo

Cipla share news, announcements and annual reports

NSE: CIPLABSE: 500087Pharmaceuticals & BiotechnologyLarge Cap

Cipla Limited · Face value ₹2 · Listed Jul 1983 on BSE, Feb 1995 on NSE
Last close ₹1,378.90up ₹20.90 (1.54%)BSE ₹1,380.00

Share price at the NSE close on 30 Oct 2026. Previous close ₹1,358.00.

30 Oct: open ₹1,362.00, high ₹1,381.70, low ₹1,357.00

52-week range of traded prices to 30 Oct 2026
₹1,165.70Low, 2 Apr 2026₹1,593.30High, 30 Oct 2025
Market cap
₹1,11,397 Cr99th largest listed
P/E
38.45
P/B
3.15
Dividend yield
0.94%
ROE
8.5%
ROCE
9.7%
Debt to equity
0.01
Volume, NSE
14,36,66155.4% delivered

Cipla share news and announcements

1,563 announcements, routine notices left out, newest first. Page 32 of 32.

  1. Jul 2007

    • 25 Jul · Meeting

      Cipla Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on August 24, 2007.
    • 20 Jul · Miscellaneous

      Cipla Ltd. has submitted to the Exchange a copy of Financial Review - Period ended June 2007 - a note displayed on the website www.cipla.com. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 20 Jul · Dividend

      Cipla Ltd. has informed the Exchange that the Board of Directors at its Meeting held on July 20, 2007 declared dividend of Rs.2/- per equity share for the year ended March 31, 2007. Further, the dates of closure of Register of Members and purpose are: August 10, 2007 to August 24, 2007 for dividend and date from which the dividend is payable: On or before September 23, 2007. Further, the statement of the financial results for the year ended March 31, 2007 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 20 Jul · Results

      Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 90183 lacs for quarter ending on 30-JUN-2007 against Rs. 86358 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 11976 lacs for the quarter ending on 30-JUN-2007 against Rs. 17043 lacs for the quarter ending on 30-JUN-2006.
    • 13 Jul · Board meeting

      Inter-alia to consider the Annual Accounts for the year ended March 31, 2007, Recommendation of Dividend, if any and Unaudited Financial Results for the first quarter ended June 30, 2007.
  2. Jun 2007

    • 7 Jun · News Verification

      News Verification : The media had reports that Reliance Industries Ltd may acquire a stake in the company. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Cipla Ltd. has vide its letter inter-alia stated, "The Company denies the rumour appearing in the news item."
  3. May 2007

    • 5 May · Miscellaneous

      Cipla Ltd. had informed the Exchange on May 05, 2007 that "This has reference to our letters dated 5th September 2003, 1st December 2003, 13th April, 2007 and Various periodic disclosures made to the Stock Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India demanding an aggregate of Rs. 748.27 crores alongwith interest which according to them was allegedly overcharged by the Company till July 2003 in respect of five drugs. The Company has now received further demand notices where the Government has demanded an amount of Rs. 193.65 crores inclusive of interest which according to them was allegedly overcharged by the Company during the period August 2003 to March 2006 in respect of the same five drugs. These notices are contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable."
  4. Apr 2007

    • 26 Apr · Miscellaneous

      Cipla Ltd. has submitted to the Exchange on April 26, 2007, a copy of Financial Review - Period ended March 2007. The details of the same shall be available, on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 23 Apr · E-mail ID for Investor Complaints

      Cipla Ltd. has informed the Exchange that "An exclusive e-mail id viz: cosecretary@cipla.com already exists in the Company for the purpose of redressal of investor grievances".
    • 19 Apr · Board meeting

      Meeting on 26 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
    • 13 Apr · Miscellaneous

      Cipla Ltd. has informed the Exchange about various periodic disclosures made to the Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India demanding an aggregate of Rs.180.37 crores, being 50% of Rs.360.75 crores which according to them was allegedly overcharged by the Company till July 2003 in respect of five drugs.The Company has now received notices where the government has demand entire 100% of the aforesaid amount along with interest aggregating to Rs.748.27 crores. These notices are contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that the notices of the government are not tenable and sustainable.
  5. Jan 2007

    • 23 Jan · Miscellaneous

      Cipla Ltd. has submitted to the Exchange a copy of the note titled "Financial Review - Period ended December 2006". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 16 Jan · Board meeting

      Meeting on 23 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”